Liver Tumors: New Technologies and New Managements 2013 is a conference that covers topics such as:
- Diagnostic modalities and best approach For cholangiocarcinoma, hepatocellular carcinoma, neuroendocrine tumors and colorectal tumors
- Subtleties of underlying conditions and comorbidities among patients with hepatocellular carcinoma
- Strategies for the use of individual and combination therapies
- The full range of treatment options currently available for treating cholangiocarcinomas, hepatocellular carcinomas, neuroendocrine tumors and colorectal tumors
- Mechanisms of disease and the relevance to the future development of molecular-tailored diagnostic and treatment modalities for cholangiocarcinomas, hepatocellular carcinomas, neuroendocrine tumors and colorectal tumors
- Importance and utility of the multidisciplinary approach to the treatment of cholangiocarcinomas, hepatocellular carcinomas, neuroendocrine tumors and colorectal tumors
- How combining treatment options for colorectal tumors can achieve successes that transcend any single modality
- New standards for determining the indications and contraindications for surgical intervention of colorectal cancers, cholangiocarcinomas and neuroendocrine tumors
- Rationale and success of new, more aggressive treatment strategies for neuroendocrine tumors
Liver Tumors: New Technologies and New Managements 2013 brings together surgical oncologists, gastroenterologists, surgeons and other healthcare professionals who treat patients with primary or metastatic liver tumors and primary care physicians.